Skip to content
Clinical Trials – home

Methylprednisolone: Uses, Effects, and Clinical Trials

29 / 59
trials open to patients / all trials
24+
Countries

In short

Methylprednisolone is a corticosteroid medication that has been the subject of various clinical trials for its potential in treating different medical conditions. This article provides an overview of recent studies investigating the use of methylprednisolone in areas such as eye surgery, esophageal burns, inner ear disorders, and gout treatment. We'll explore the drug's effectiveness, safety profile, and potential applications across different patient populations.

Introduction

Methylprednisolone is a corticosteroid medication used to treat various inflammatory conditions. It is a synthetic steroid that mimics the effects of hormones produced naturally by the adrenal glands. Methylprednisolone is available under several brand names, including Medrol, Solu-Medrol, and Depo-Medrol.

Medical Uses

Methylprednisolone is used to treat a wide range of conditions characterized by inflammation or overactivity of the immune system. Based on the clinical trials reviewed, some key uses include:

  • Acute severe asthma: Methylprednisolone is used to manage severe asthma attacks, helping to reduce inflammation in the airways and improve breathing.
  • Membranous nephropathy: This is a kidney disorder where methylprednisolone, often in combination with other drugs, is used to suppress the immune system and reduce damage to the kidneys.
  • Post-operative inflammation: Methylprednisolone can be used to control inflammation after surgeries, such as cataract or glaucoma procedures.

Administration and Dosing

Methylprednisolone can be administered in various ways, depending on the condition being treated and the specific formulation used:

  • Intravenous (IV) injection: For acute conditions like severe asthma attacks, methylprednisolone may be given as an IV injection. For example, one study used 1g IV methylprednisolone daily for three doses.
  • Oral tablets: For longer-term treatment, oral methylprednisolone may be prescribed. In one study, patients took 0.5mg/kg/day orally for 27 days.
  • Ophthalmic (eye) drops: For eye conditions, methylprednisolone may be formulated as eye drops. These are typically used several times a day, with frequency decreasing over time.

It's important to note that dosing can vary significantly based on the specific condition being treated and individual patient factors. Always follow your doctor's instructions carefully when taking methylprednisolone.

Efficacy in Clinical Trials

Several clinical trials have investigated the effectiveness of methylprednisolone for various conditions:

  • Acute severe asthma: A study is comparing the efficacy of methylprednisolone to hydrocortisone in managing acute severe asthma. Researchers are looking at factors such as improvement in vital signs, respiratory rate, and peak expiratory flow rate to determine which medication is more effective.
  • Membranous nephropathy: A trial is comparing a treatment regimen including methylprednisolone to a newer approach using tacrolimus and rituximab. The study is measuring outcomes such as remission rates, preservation of kidney function, and occurrence of relapses.
  • Post-operative inflammation: Studies have compared different formulations of prednisolone (a similar corticosteroid) for controlling inflammation after eye surgeries. While not directly about methylprednisolone, these studies provide insight into the effectiveness of corticosteroids in managing post-surgical inflammation.

Potential Side Effects

While methylprednisolone can be very effective, it can also cause side effects. The clinical trials reviewed mention monitoring for adverse events, which could include:

  • Increased risk of infections
  • Changes in blood sugar levels
  • Changes in blood pressure
  • Mood changes or sleep disturbances
  • Fluid retention

It's important to discuss potential side effects with your healthcare provider and report any unusual symptoms while taking methylprednisolone.

Comparisons to Other Medications

The clinical trials provide some comparisons between methylprednisolone and other medications:

  • Hydrocortisone: A study is directly comparing methylprednisolone to hydrocortisone for treating acute severe asthma.
  • Tacrolimus and Rituximab: For membranous nephropathy, a treatment regimen including methylprednisolone is being compared to a newer approach using tacrolimus and rituximab.
  • Other corticosteroid formulations: While not directly about methylprednisolone, studies comparing different formulations of prednisolone for eye inflammation suggest that there can be differences in effectiveness between seemingly similar corticosteroid medications.

Frequently Asked Questions

How quickly does methylprednisolone work?

The speed of action can vary depending on the condition being treated and the method of administration. For acute conditions like severe asthma attacks, IV methylprednisolone can start working within hours. For chronic conditions, it may take days or weeks to see the full effect.

Can I stop taking methylprednisolone suddenly?

No, you should not stop taking methylprednisolone abruptly without consulting your doctor. Corticosteroids like methylprednisolone often require a gradual reduction in dose to allow your body to adjust.

Is methylprednisolone the same as prednisone?

While both are corticosteroids, methylprednisolone and prednisone are different medications. Methylprednisolone is generally considered more potent than prednisone. Your doctor will determine which medication is most appropriate for your specific condition.

Glossary

  • Corticosteroid - A class of steroid hormones produced in the adrenal cortex or made synthetically. They have various metabolic functions and are used to treat inflammation.
  • Membranous nephropathy - A kidney disorder characterized by thickening of the glomerular basement membrane, leading to protein loss in the urine.
  • Peak expiratory flow rate - A measure of how quickly you can exhale air from your lungs, often used to monitor asthma.
CharacteristicDetails
Drug ClassCorticosteroid
Main UsesAcute severe asthma, membranous nephropathy, post-operative inflammation
Administration RoutesIntravenous injection, oral tablets, ophthalmic drops
Common Side EffectsIncreased infection risk, changes in blood sugar and blood pressure, mood changes
Comparator Drugs in TrialsHydrocortisone, Tacrolimus, Rituximab

Questions people often ask

Conditions where Methylprednisolone is being studied

Each condition opens its own overview and trial list

Trials with Methylprednisolone

Recruiting trials first

See all 59 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).